Maximillion Jensen, DDS | |
7000 Uula St, Barrow, CA 99723 | |
(907) 852-9221 | |
Not Available |
Full Name | Maximillion Jensen |
---|---|
Gender | Male |
Speciality | Dentist |
Location | 7000 Uula St, Barrow, California |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1205203627 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
122300000X | Dentist | 65015 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Maximillion Jensen, DDS 1296 Agvik Street, Apt 18, Barrow, AK 99723 Ph: (505) 270-3987 | Maximillion Jensen, DDS 7000 Uula St, Barrow, CA 99723 Ph: (907) 852-9221 |
News Archive
Aethlon Medical, Inc., the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that its researchers have demonstrated the ability of the Aethlon Hemopurifier® to capture immunosuppressive exosomes derived from individuals with metastatic melanoma.
Wake Forest Baptist Medical Center has received an $18 million, five-year grant from the National Cancer Institute's Community Oncology Research Program to design and conduct community-based, multi-center screening, prevention and control cancer clinical trials.
A major breakthrough in mental health has been developed, a cooperative venture between the National Bipolar Foundation and the MedicAlert Foundation; a preventative care program called "Safe 'til Stable." It provides vital medical information to emergency responders in time of need through our live 24-hour emergency response service.
Wake Forest University Baptist Medical Center in September will begin a two-year study to determine whether a lack of trust of the U.S. medical system is a factor behind a higher mortality rate among Hispanics with HIV/AIDS, the Winston-Salem Journal reports.
By combining local radiation therapy and anti-cancer vaccines with checkpoint inhibitors, researchers from the University of Chicago, working with mice, were able to increase the response rate for these new immunotherapy agents.
› Verified 5 days ago